About us
Our expertise
Commercial >
We provide commercial consulting and advisory solutions across the product development and commercialization lifecycle.

Portfolio, Licensing & Development >

Commercialization & Growth >

Data Strategy & Analytics >

Value, Pricing & Access >
Our expertise across scientific and commercial domains delivers a collaborative and bespoke approach to maximize patient access and the commercial success of your innovations.

Value, Pricing & Access Strategy >

HEOR Evidence Generation >

Evidence Synthesis & RWE Generation >

Medical & Scientific Affairs >
We provide world-class thought partnership and solutions that enhance the business impact of medical and scientific affairs.

Asset Development >

Launch Strategy >

Implementation & Impact >

Centers of Excellence >
Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.

Advanced Clinical Technologies >

Forecasting & Financial Modeling >

Integrated Insights >
AI at Putnam

A strategic thought partner for your AI journey

Learn more
Join Putnam
Insights

Contact

Identifying micro-moments and how to leverage them

0 mins read

20 September 2022

Insights

More insights.

See all insights

Jump to a slide with the slide dots.

MAPS EMEA 2025: Driving Transformation and Excellence in Medical Affairs

Explore how MAPS EMEA 2025 redefined Medical Affairs - patient-centricity, AI, evidence generation & launch excellence take center stage

Why AI Needs Humans: The Critical Thinking Advantage in Pharmaceutical Commercialization

AI speeds pharma insights, but human experts turn them into action. ClarityNav blends AI power with strategic, real-world expertise.

Radosław Skowron

Acceptance of Artificial Intelligence in Evidence and Dossier Developments by HTA bodies: Challenges and Opportunities

AI is transforming Health Technology Assessment, but trust, transparency, and clear HTA guidance are key to broader acceptance.